Copyright Reports & Markets. All rights reserved.

China Urology Drugs Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Urology Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 α (alpha) - blockers Market Performance (Volume)
      • 2.1.2 5 α-reductase inhibitors Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 α (alpha) - blockers Market Performance (Value)
      • 2.1.2 5 α-reductase inhibitors Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospital Market Performance (Volume)
      • 3.1.2 Clinic Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Astellas
      • 4.1.1 Astellas Profiles
      • 4.1.2 Astellas Product Information
      • 4.1.3 Astellas Urology Drugs Business Performance
      • 4.1.4 Astellas Urology Drugs Business Development and Market Status
    • 4.2 Endo
      • 4.2.1 Endo Profiles
      • 4.2.2 Endo Product Information
      • 4.2.3 Endo Urology Drugs Business Performance
      • 4.2.4 Endo Urology Drugs Business Development and Market Status
    • 4.3 GP Pharm
      • 4.3.1 GP Pharm Profiles
      • 4.3.2 GP Pharm Product Information
      • 4.3.3 GP Pharm Urology Drugs Business Performance
      • 4.3.4 GP Pharm Urology Drugs Business Development and Market Status
    • 4.4 Tolmar
      • 4.4.1 Tolmar Profiles
      • 4.4.2 Tolmar Product Information
      • 4.4.3 Tolmar Urology Drugs Business Performance
      • 4.4.4 Tolmar Urology Drugs Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 China Urology Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 China Urology Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 China Urology Drugs Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 South China Market Performance for Manufacturers
      • 6.1.1 South China Urology Drugs Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 South China Urology Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 South China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 South China Urology Drugs Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 East China Market Performance for Manufacturers
      • 6.2.1 East China Urology Drugs Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 East China Urology Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 East China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 East China Urology Drugs Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 Southwest China Market Performance for Manufacturers
      • 6.3.1 Southwest China Urology Drugs Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 Southwest China Urology Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 Southwest China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 Southwest China Urology Drugs Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Northeast China Market Performance for Manufacturers
      • 6.4.1 Northeast China Urology Drugs Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Northeast China Urology Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Northeast China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Northeast China Urology Drugs Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 North China Market Performance for Manufacturers
      • 6.5.1 North China Urology Drugs Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 North China Urology Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 North China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 North China Urology Drugs Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Central China Market Performance for Manufacturers
      • 6.6.1 Central China Urology Drugs Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Central China Urology Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Central China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Central China Urology Drugs Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Northwest China Market Performance for Manufacturers
      • 6.7.1 Northwest China Urology Drugs Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Northwest China Urology Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Northwest China Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Northwest China Urology Drugs Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration

    7 China Urology Drugs Market Performance (Sales Point)

    • 7.1 China Urology Drugs Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 China Urology Drugs Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 China Urology Drugs Price (USD/Unit) by Regions 2013-2018
    • 7.4 China Urology Drugs Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 South China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 East China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 Southwest China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Northeast China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 North China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Central China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Northwest China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospital Industry
    • 11.2 Clinic Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 China Urology Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 China Urology Drugs Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 South China Urology Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 East China Urology Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 Southwest China Urology Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Northeast China Urology Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 North China Urology Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Central China Urology Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Northwest China Urology Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 α (alpha) - blockers Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 5 α-reductase inhibitors Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospital Sales and and Growth Rate 2019-2024
      • 12.4.3 Clinic Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 China Urology Drugs Price (USD/Unit) Trend 2019-2024
      • 12.5.2 China Urology Drugs Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Urology Drugs for these regions, from 2012 to 2023 (forecast), including
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

    China Urology Drugs market competition by top manufacturers/players, with Urology Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astellas
    Endo
    GP Pharm
    Tolmar
    ...

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    α (alpha) - blockers
    5 α-reductase inhibitors

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Urology Drugs for each application, including
    Hospital
    Clinic

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now